First Trust Advisors LP acquired a new position in Everus (NYSE:ECG - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 21,539 shares of the company's stock, valued at approximately $1,416,000.
A number of other hedge funds also recently made changes to their positions in ECG. Dimensional Fund Advisors LP bought a new position in Everus during the fourth quarter valued at $120,578,000. Alpha Wave Global LP bought a new stake in Everus in the 4th quarter valued at about $9,091,000. MSH Capital Advisors LLC purchased a new position in shares of Everus in the fourth quarter worth about $270,000. Marshall Wace LLP bought a new stake in shares of Everus in the fourth quarter valued at approximately $7,068,000. Finally, NewEdge Advisors LLC purchased a new stake in shares of Everus during the 4th quarter valued at approximately $1,070,000.
Insider Buying and Selling at Everus
In other news, CFO Maximillian J. Marcy purchased 1,300 shares of the business's stock in a transaction dated Tuesday, February 25th. The shares were purchased at an average price of $38.99 per share, for a total transaction of $50,687.00. Following the completion of the acquisition, the chief financial officer now directly owns 5,508 shares in the company, valued at $214,756.92. This represents a 30.89 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Rocca Michael Della bought 1,050 shares of the business's stock in a transaction on Tuesday, February 18th. The stock was bought at an average cost of $47.56 per share, with a total value of $49,938.00. Following the transaction, the director now owns 2,027 shares in the company, valued at $96,404.12. This trade represents a 107.47 % increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders purchased 3,750 shares of company stock worth $153,853. 0.21% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
Separately, Stifel Nicolaus lowered their target price on shares of Everus from $67.00 to $55.00 and set a "buy" rating on the stock in a research note on Wednesday, April 9th.
View Our Latest Stock Analysis on ECG
Everus Trading Down 0.5 %
Shares of ECG traded down $0.25 during mid-day trading on Friday, reaching $48.02. The company's stock had a trading volume of 781,592 shares, compared to its average volume of 720,109. Everus has a 52 week low of $31.38 and a 52 week high of $77.93. The stock's fifty day moving average price is $39.31. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.50 and a current ratio of 1.58.
Everus (NYSE:ECG - Get Free Report) last posted its quarterly earnings results on Tuesday, February 11th. The company reported $0.67 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.73 by ($0.06). As a group, equities research analysts forecast that Everus will post 2.49 earnings per share for the current year.
Everus Company Profile
(
Free Report)
Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.
Featured Stories

Before you consider Everus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Everus wasn't on the list.
While Everus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.